ENTPD1 and neoplasm: Evaluation of exhaustion markers in TILs following tumor-cell rechallenge revealed a slight decrease in the frequency of LAG3+ cells, but no changes in PD1+ or CD39+ expression were observed in ABE-TILs (Figure 4E).